Prof Trish Livingston

Professor Livingston has been the Associate Dean – Research in the Faculty of Health, Deakin University since 2012. This role involves providing leadership and strategic direction regarding the Faculty’s research agenda by providing research advice to the Executive Dean-Health, Heads of Schools, Institute and Strategic Research Centre Directors, as well as senior and junior researchers.

Professor Livingston is a researcher and member of the Institute for Health Transformation, Centre for Quality and Patient Safety. Her key research focus is in the development and implementation of clinical and community based interventions, programs, policy initiatives and guidelines to improve health delivery and outcomes for people affected by cancer and their carers. Her studies have demonstrated gaps in service delivery and she and her teams have developed recommendations, changes in clinical and community practice, and policy initiatives to improve consumer access to health services.

Despite working part-time from 1997-2012 and now having an administrative load in her current role as Associate Dean Research, Professor Livingston has generated over $7 million in successful grant applications including NHMRC (as Principal Investigator or Co-Investigator), ARC (Principal Investigator), Department of Health and Vichealth grants; published over 155 publications in refereed journals and contributed to over 180 presentations at international, national and local conferences.
Based on Scopus citation data, Prof Livingston’s overall Field Weighted Citation Impact (FWCI) for outputs published is 1.59, indicating her publications have received 59% more citations than is average for similar publications (same publication year, publication type and discipline) and her publications have been cited across 84 countries worldwide. She is also recognised internationally with an Affiliated Professorship in Supportive Technology in Cancer Treatment at University of Copenhagen (ranked #38 in the world: Academic Ranking of World Universities).

Professor Livingston is currently the Principal Investigator on a NHMRC Partnership grant (2015-9, $765,000) investigating smartphone technology to support people diagnosed with cancer.  and was a Principal Investigator on a multi-state, multi-centre NHMRC-funded randomised controlled trial (2014-8; $542,000) investigating carer burden among carers of cancer patients. She led a multi-centre randomised controlled trial with funding from ARC and Prostate Cancer Foundation of Australia investigating the impact of a 12 week exercise program among men with prostate cancer; led the evaluation of a Department of Health survivorship program at Barwon Health and Western region of Victoria, and is co-investigator on other externally funded projects.

Her research incorporates both qualitative and quantitative methodologies, across both clinical and community settings. Each of these roles has required academic leadership, innovation and motivation skills to develop and manage the projects and associated budgets, as well as advanced interpersonal and problem solving skills, extensive collaboration to ensure their successful completion within the specified time frames. These programs of research have enabled her to build capacity by successfully training Honours and HDR students, mentoring academic staff, research assistants and casual staff. She has supervised 14 Higher Degree scholars to completion, and 7 Honours students, 3 of which received a 90% or higher thesis results.

Prof Livingston is Chair of the NHMRC Clinical Trials and Cohort Studies Grants review panel, panel member for the NHMRC Partnership Grants Scheme, Movember Project Grant Scheme, Prostate Cancer Foundation of Australia, John Mills Young Investigator Fellowship Scheme and Epworth Healthcare Project Scheme. She is also an active member of Research Australia’s Roundtable.

Professor Livingston has supervised 20 Higher Degree and Honours scholars to completion, 4 of which received a 90% or higher thesis result; 2 received the School Prize for Excellence, one student received the  Executive Dean Health award for best Honours thesis and a PhD student received the Vice-Chancellor’s Alfred Deakin Award for Best Doctoral Thesis.

University and Faculty Committees

Professor Livingston is involved in a wide range of Faculty and University committees:
Member, University Research Advisory Committee
Member, University Research & Research Training Committee
Chair, Faculty Research & Research Training
Chair, Faculty Grants Committee
Chair, Faculty Central Research Grants Scheme Panel
Chair, Faculty HDR Scholarships Panel
Member, Faculty Board
Member, Faculty Executive Group
Member, Faculty Research Leadership Group
Member, Academic Promotions Committee
Member, Deakin University Human Research Ethics Committee (2010-12)
Member, Eastern Health Human Research Ethics Committee (2007-10)

Conference participation - abridged

1. Livingston PM, Ashley D, Chambers S, White V, Chirgwin J, Krishnasamy M, Mihalopoulos C; Botti M; Parente P, Woollett A; Boltong A; Ugalde A; OMeagher C, Lau D; Simons K, Byrnes J, Reynolds J Sutton J. M-Health: Efficacy and Cost-effectiveness of a smartphone App to reduce unmet needs and distress in people with cancer (ACE): a randomized controlled trial. Asia-Pacific J Clin Oncol; Nov 2014.
2. Yuen E, Knight T, Dodson S, Ricciardelli L, Burney S, Livingston PM. Development of a new questionnaire to assess cancer caregiver health literacy: Item generation and content validity testing Asia-Pacific J Clin Oncol; Nov 2014. 
3. Maryann Street, Goetz Ottmann, Megan-Jane Johnstone, Julie Considine, Patricia Livingston. Advance Care Planning and Emergency Care. ICEN Oct Perth; 2014.
4. Livingston PM, Craike M, Salmon J, Courneya K, Gaskin C, Fraser S, Mohabi M, Botti M, Broadbent S, Kent B. Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: a multicentre cluster randomized controlled trial [ENGAGE].UICC; Dec 2014.
5. Fraser S, Owen P, Craike M, Salmon J, Courneya K, Gaskin C, Broadbent S, Livingston PM. Fitness levels of participants in the ENGAGE clinician referral and exercise program for men who have completed active treatment for prostate cancer: a multicentre cluster randomized controlled trial. 14th Australasian Prostate Cancer Conference; Melbourne; August 2014.
6. Livingston PM, Craike M, Salmon J, Courneya K, Gaskin C, Fraser S, Mohabi M, Botti M, Broadbent S, Kent B. Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: a multicentre cluster randomized controlled trial [ENGAGE]. 14th Australasian Prostate Cancer Conference; Melbourne; August 2014.
7. Livingston PM, Craike M, Salmon J, Courneya K, Gaskin C, Fraser S, Mohabi M, Botti M, Broadbent S, Kent B Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: a multicentre cluster randomized controlled trial [ENGAGE]. ANZUP Cancer Trials Group; Melbourne; July 2014. Winner, Best of the Best poster presentation.
8. Owen P, Fraser S, Craike M, Salmon J, Courneya K, Gaskin C, Broadbent S, Livingston PM. The efficacy of a clinician referred exercise training program on markers of cardiometabolic risk for prostate cancer survivors. 14th Australasian Prostate Cancer Conference; Melbourne; August 2014.
9. Livingston PM, Osborne R, Botti M, Heckel L, Gunn K, Chirgwin J. A Multi-Centre  Randomised Controlled Trial to Test the Efficacy and Cost Effectiveness of an Intervention to Reduce Carer Burden Among Caregivers of Cancer Patients. Asia-Pacific J Clin Oncol 2013; 96: Abs 338.
10. Hose K, Craike M, Courneya K, Harrison S, Livingston PM. What factors influence whether a person with Multiple Myeloma will participate in a Physical Activity Program? Haematology Society of Australia & New Zealand conference; Queensland; Oct; 2013.
11. Rasmussen B, Maindal HT, Livingston PM, Dunning T; Lorentzen  V. Life Transitions Management: An Australian-Danish qualitative study among young people with type 2 diabetes in the age between 20-40 years World Diabetes Congress; Croatia; December 2013.
12. Owen P, Daly R, Livingston PM, Fraser S. Musculoskeletal health in prostate cancer patients treated with androgen deprivation therapy: A review of current practice guidelines. Prostate Cancer World Conference; Melbourne; August 2013.
13. Gardner J, Livingston PM, Fraser S. The effects of exercise on treatment side effects for prostate cancer patients receiving androgen deprivation therapy: a systematic review. Prostate Cancer World Conference; Melbourne; August 2013.

 

Prof Livingston is an assessor for NHMRC, ARC, UK Project Grant Review Board, and Health Review Board of Ireland. 

Collaborations either nationally or internationally, include:
Professor Kerry Courneya, University of Alberta, Canada
Professor Elizabeth Maunsell, Laval University, Canada
Professor Annie Anderson, University of Dundee, United Kingdom
Assistant Professor Sylvie Lambert, McGill University, Canada
Professor Stewart Dunn, Sydney University
Professor Phyllis Butow, Sydney University
Professor Meinir Krishnasamy, University of Melbourne
Associate Professor Victoria White, Cancer Council Victoria
Professor Michael Jefford, Peter MacCallum Cancer Centre

Post-Doctoral Fellowship awarded by the National Health & Medical Research Council (Public Health; 1997-2003; p/t)

Sutherland Foundation Scholarship (1996)

High Commendation for the inaugural Premier's Award for Medical Research awarded by the Premier of Victoria (1995)